Abbvie Inc Stock Market Value
| ABBV Stock | USD 223.93 3.16 1.43% |
| Symbol | AbbVie |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 6.56 | Earnings Share 1.32 | Revenue Per Share | Quarterly Revenue Growth 0.091 |
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AbbVie 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AbbVie's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AbbVie.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in AbbVie on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding AbbVie Inc or generate 0.0% return on investment in AbbVie over 90 days. AbbVie is related to or competes with Johnson Johnson, AstraZeneca PLC, Novartis, Novo Nordisk, Merck, UnitedHealth Group, and Amgen. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide More
AbbVie Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AbbVie's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AbbVie Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 8.22 | |||
| Value At Risk | (2.86) | |||
| Potential Upside | 2.95 |
AbbVie Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AbbVie's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AbbVie's standard deviation. In reality, there are many statistical measures that can use AbbVie historical prices to predict the future AbbVie's volatility.| Risk Adjusted Performance | 0.0025 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.17) | |||
| Treynor Ratio | (0.17) |
AbbVie January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0025 | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 1.13 | |||
| Coefficient Of Variation | (24,784) | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.64 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.17) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 8.22 | |||
| Value At Risk | (2.86) | |||
| Potential Upside | 2.95 | |||
| Skewness | (0.25) | |||
| Kurtosis | 1.29 |
AbbVie Inc Backtested Returns
AbbVie Inc secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. AbbVie Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AbbVie's mean deviation of 1.13, and Risk Adjusted Performance of 0.0025 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0972, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AbbVie's returns are expected to increase less than the market. However, during the bear market, the loss of holding AbbVie is expected to be smaller as well. At this point, AbbVie Inc has a negative expected return of -0.004%. Please make sure to confirm AbbVie's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if AbbVie Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.03 |
Very weak reverse predictability
AbbVie Inc has very weak reverse predictability. Overlapping area represents the amount of predictability between AbbVie time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AbbVie Inc price movement. The serial correlation of -0.03 indicates that only 3.0% of current AbbVie price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 22.36 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.